Oncology & Rare Disease: Reach your goals faster for Phase II and III clinical trials

Trust our technology and expertise to support your oncology and rare disease research

Cmed is a full service, global CRO with over 20 years of clinical research experience including 15 years of design and delivery of virtual and patient centric trials.

Solutions to push your clinical trial across the line

  • Through processes to support even the most complicated patient identification, product manufacture, and dose administration timeframes
  • Technology enhanced safety and medical oversight using real-time visualizations to provide insights into your study data
  • Established relationships with specialist laboratories, imaging, eCOA, and other service providers
  • Centralized and integrated data review including onsite and remote source review, plus central review including clinical, medical, and data science methods

Cmed by the numbers

2 Site CDAs as fast as 2 days
29 Central IRB submission and approval as fast as 29 days
4 Database Locks within 4 weeks of LPLV
14 Project plan final in 14 days
100% database live before First Patient In (FPI)
10 TFLs delivered within 10 days of database lock
100% of sites activated ahead of original target FPI
64,000+ Patients in Oncology and Rare Disease
7,000+ Sites across US, EU, and APAC
78 Studies in 78 countries
250+ Oncology studies delivered
128 Rare disease studies

Our capabilities for Phase II and Phase III trials

Our dedicated Phase II and III study teams have an average of 15+ years’ experience with innovative strategies to avoid hurdles in your next study.

  • Experts to support agency engagement, program strategy, protocol development, and feasibility
  • Use of Home Visit technology, online medical review and tracking, cross-functional interactive visualizations, eConsent and other systems such as eSAE, eCTD, eTMF and eSource
  • Options for dedicated product and lab logistics management by clinically experienced staff
  • Expert third party data handling including specialty labs like NGS, bespoke biomarkers, advanced imaging, eCOA plus many others
  • Submissions, publications, and conference support
  • Successful delivery in functional and composite service models


We anticipate. We adapt. We embrace every challenge. We are where you want to be.

Get in touch with us today to discuss your upcoming clinical trial needs and how our experts can help innovate and avoid hurdles. Email us at